Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 92.11 USD 0.36%
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Research & Development Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Research & Development
-$59.7m
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Research & Development
-$166m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ICU Medical Inc
NASDAQ:ICUI
Research & Development
-$88.5m
CAGR 3-Years
-26%
CAGR 5-Years
-12%
CAGR 10-Years
-20%
Align Technology Inc
NASDAQ:ALGN
Research & Development
-$351.5m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
Lantheus Holdings Inc
NASDAQ:LNTH
Research & Development
-$149.6m
CAGR 3-Years
-48%
CAGR 5-Years
-49%
CAGR 10-Years
-27%
Merit Medical Systems Inc
NASDAQ:MMSI
Research & Development
-$83.9m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-9%

See Also

What is Haemonetics Corp's Research & Development?
Research & Development
-59.7m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Research & Development amounts to -59.7m USD.

What is Haemonetics Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-2%

Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Haemonetics Corp have been -13% over the past three years , -13% over the past five years , and -2% over the past ten years .

Back to Top